Industry Looks To FDA’s New Combo Products Chief For Answers

FDA's Office of Combination Products says it is getting back on track with new leadership in place after months of flux. Industry meanwhile is pushing the office to accelerate the release of rules and guidelines to help companies navigate the relatively new area of regulation

More from Archive

More from Medtech Insight